29836-01-9 Usage
Uses
Used in Biochemical Research:
8-(methylsulfanyl)-9-pentofuranosyl-9H-purin-6-amine is used as a building block for the synthesis of various bioactive molecules and pharmaceutical drugs. Its unique structure and properties make it a valuable compound for studying the mechanisms of genetic information storage and transmission.
Used in Pharmaceutical Development:
8-(methylsulfanyl)-9-pentofuranosyl-9H-purin-6-amine is used as a key component in the development of new drugs targeting various diseases. Its potential biological activity and chemical diversity make it a promising candidate for drug discovery and therapeutic applications.
Used in DNA and RNA Analysis:
8-(methylsulfanyl)-9-pentofuranosyl-9H-purin-6-amine is used as a reference compound in the analysis and characterization of DNA and RNA structures. Its presence in nucleic acids allows researchers to study the interactions between genetic material and other molecules, contributing to a better understanding of genetic processes.
Check Digit Verification of cas no
The CAS Registry Mumber 29836-01-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,8,3 and 6 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 29836-01:
(7*2)+(6*9)+(5*8)+(4*3)+(3*6)+(2*0)+(1*1)=139
139 % 10 = 9
So 29836-01-9 is a valid CAS Registry Number.
29836-01-9Relevant academic research and scientific papers
Synthesis and in vitro stability of nucleoside 5′-phosphonate derivatives
Vertuani, Silvia,Baldisserotto, Anna,Varani, Katia,Borea, Pier Andrea,De Marcos Maria Cruz, Bonache,Ferraro, Luca,Manfredini, Stefano,Dalpiaz, Alessandro
supporting information; experimental part, p. 202 - 209 (2012/09/07)
Nucleoside derivatives are largely synthesized and tested to investigate their influence on platelet aggregation. It's well known that P2Y receptors play an important role in the regulation of platelet function and, as consequence, in controlling atherothrombotic events. The research of compounds that antagonize P2Y1 and, in particular, P2Y12 receptors is of great interest in the aim to obtain platelet aggregation inhibitors that are effective in the prevention and treatment of arterial thrombosis. In this study we present the synthesis and in vitro metabolic stability in human blood and rat liver homogenate of a new class of nucleoside derivatives, in particular 5′-phosphonate adenosine, inosine, guanosine and thioadenosine analogues also modified at the ribose moiety. On the basis of the results obtained we can hypothesize compounds 4 and 18 to have in vivo a relatively high stability.
